Physician profile
Efraim Vela
NPI 1912079401
$2,475.14
in general payments reported to CMS, 2019-2025
9 companies · $232 in 2025
The $232 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,217 · 2020: $320 · 2022: $119 · 2023: $92.79 · 2024: $494 · 2025: $232.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $682 · Education: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $681.73 |
| Education | $137.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Applied Medical Resources Corporation | $1,167.09 | 2019-2020 | |
| Coopersurgical, INC. | $570.44 | 2019-2025 | Advincula Delineator Uterine Manipulator, Summit Doppler, Bakri |
| Medical Device Business Services, INC. | $277.47 | 2024 | Stratafix |
| Intuitive Surgical, INC. | $152.44 | 2020 | |
| Organon LLC | $135.61 | 2025 | Nexplanon, Jada System |
| Baxter Healthcare | $108.87 | 2020 | |
| Davol INC. | $24.73 | 2024 | Arista Ah Flexitip |
| Ethicon US, LLC | $24.30 | 2024 | Stratafix |
| Duchesnay USA Incorporated | $14.19 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Efraim Vela listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.